Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.43 |
| ▸ | IDO1 | P14902 | 10/20 | 0.37 |
| ▸ | TDO2 | P48775 | 3/20 | 0.34 |
| ▸ | PNMT | P11086 | 2/20 | 0.33 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20170516 | 0.87 | TAAR1 (0.42) | IDO1TDO2CYP11B1CYP11B2 | |
| SCHEMBL16730945 | 0.72 | CYP11B1 (0.48) | IDO1P2RX7CYP11B1CYP11B2 | |
| SCHEMBL3787333 | 0.69 | DPP4 (0.73) | DPP4PNMTLOXL2 | |
| SCHEMBL27519958 | 0.66 | DPP4 (0.61) | DPP4PNMT | |
| SCHEMBL27527398 | 0.65 | DPP4 (0.59) | DPP4PNMTLOXL2 | |
| SCHEMBL25022479 | 0.64 | DPP4 (0.44) | DPP4PNMT | |
| SCHEMBL17794539 | 0.64 | DPP4 (0.58) | DPP4PNMTLOXL2 | |
| SCHEMBL3288611 | 0.63 | DPP4 (0.69) | DPP4PNMTLOXL2CYP11B1CYP11B2 | |
| SCHEMBL27467061 | 0.63 | DPP4 (0.52) | DPP4PNMTCYP11B1CYP11B2 | |
| SCHEMBL3288789 | 0.63 | DPP4 (0.62) | DPP4TDO2LOXL2CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9975888-B2 | Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug | MERCK SHARP & DOHME CORP. (US) | 2018-05-22 | — | — | US | disclosed |